Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AV-PC chemotherapy for low-risk childhood Hodgkin lymphoma
NCT00302003Phase 3Completed
- Sponsor
- Children's Oncology Group
- Start
- Feb 2006
- Primary completion
- Mar 2012
- Modality
- Monoclonal Antibodies, Targeted Liposomes, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of pegylated liposomal doxorubicin, vincristine sulfate liposome injection, prednisone, cyclophosphamide in Hodgkin lymphoma (HL), sponsored by Children's Oncology Group. Started Feb 2006; status: completed.
02
Drugs
pegylated liposomal doxorubicinvincristine sulfate liposome injectionprednisonecyclophosphamide
03
Conditions
Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on NCT00302003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00302003.